中文名称 |
Carnosic acid
|
---|---|
中文别名 |
鼠尾草酸;鼠尾草酸(标准品);鼠尾草酸, 来源于迷迭香;鼠尾草酸液体;鼠尾草酸油;迷迭香提取物;鼠尾草酸 迷迭香提取物;鼠尾草酸 标准品;鼠尾草酸 植物提取物,标准品,对照品;(4aR,10aS)-5,6-二羟基-7-异丙基-1,1-二甲基-1,2,3,4,4a,9,10,10a-八氢菲-4a-羧酸 (合成);(4aR,10aS)-5,6-二羟基-7-异丙基-1,1-二甲基-1,2,3,4,4a,9,10,10a-八氢菲-4a-羧酸
|
英文名称 |
Carnosic acid
|
英文别名 |
CARNOSOLIC ACID;4a(2H)-Phenanthrenecarboxylic acid, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4aR,10aS)-;(4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid;CARNOSIC ACID(P);CARNOSIC ACID(P)(NOW AVAILABLE IN GRAM SIZES)(P);salvin;(4aR-trans)-1,3,4,9,10,10a-Hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-4a(2H)-phenanthrenecarboxylic acid;Carnosic Acid (Synthetic);CARNOSIC ACID(P) PrintBack;Carnosic acid from Rosmarinus officinalis;Carnosic acid;Carsonic acid;RoseOx;(4aR,10aS)-5,6-Dihydroxy-7-isopropyl-1,1-dimethyl-1,3,4,9,10,10a-hexahydro-2H-phenanthrene-4a-carboxylic acid;(4aR,10aS)-5,6-Dihydroxy-7-isopropyl-1,1-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-4a-carboxylic Acid (Synthetic);(4aR,10aS)-5,6-Dihydroxy-7-isopropyl-1,1-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-4a-carboxylic Acid;[
""
];LI791SXT24;NSC694080;(4aR,10aS)-5
|
Cas No. |
3650-09-7
|
分子式 |
C20H28O4
|
分子量 |
332.43
|
包装储存 |
-80°C, stored under nitrogen |
生物活性 |
Carnosic acid has demonstrated inhibition of oxidative stress and inflammation, suppression of cell proliferation, and antibacterial activity. |
---|---|
性状 |
Solid |
体外研究(In Vitro) |
Carnosic acid, a phenolic diterpene, is enriched in the leaves of Lamiaceae plants, and is particularly high in dried leaves of Rosmarinus officinalis L. and Salvia officinalis. Carnosic acid has demonstrated inhibition of oxidative stress and inflammation, suppression of cell proliferation, and antibacterial activity. It is widely reported that Carnosic acid has a therapeutic potential in different types of cancer, mostly based on 体外研究 experiments. Carnosic acid has also shown neuroprotective effects in experimental models of neurodegenerative diseases, mainly through activation of the antioxidant NRF2/ARE pathway. Medlife has not independently confirmed the accuracy of these methods. They are for reference only. |
运输条件 |
Room temperature or refrigerated transportation. |
储存方式 |
-80°C, stored under nitrogen |
结构分类 | |
来源 | |
参考文献 |
溶解度数据 |
体外研究:
DMSO : 130 mg/mL (391.06 mM; Need ultrasonic) 配制储备溶液
*
产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效。 体内研究:
建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*
|
---|
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。
Copyright © 2025 陌孚医药 All rights reserved 未经授权禁止拷贝本站所有资料,如有违反,将追究法律责任。
沪ICP备2023012080号 |
沪公网安备31011402010657号